3D contrast-enhanced MR angiography
- PMID: 17154188
- DOI: 10.1002/jmri.20767
3D contrast-enhanced MR angiography
Abstract
Safe, fast, accurate contrast arteriography can be obtained utilizing gadolinium (Gd) and 3D MR data acquisition for diagnosing vascular diseases. Optimizing contrast enhanced MRA (CE MRA), however, requires understanding the complex interplay between Gd injection timing, the Fourier mapping of 3D MR data acquisition and a multitude of parameters determining resolution, anatomic coverage, and sensitivity to motion artifacts. It is critical to time the bolus peak to coincide with central k-space data acquisition, which dominates image contrast. Oversampling the center of k-space allows reconstruction of multiple 3D acquisitions in rapid succession to time-resolve the passage of the contrast bolus. Parallel imaging increases resolution, shortens scan time and compresses the center of k-space into a shorter period of time, thereby minimizing motion and timing artifacts. Absence of ionizing radiation allows MRA to be repeated and combined with additional sequences to more fully characterize anatomy, flow, and physiology. Utilizing stepping table technology and thigh compression, whole body MRA is possible with a single contrast injection. As MR technology continues to advance, CE MRA becomes better and simpler to perform, increasing its efficacy in the diagnosis and management of vascular diseases.
Comment in
-
Safety risks with gadolinium-based contrast agents.J Magn Reson Imaging. 2007 Sep;26(3):816; author reply 817. doi: 10.1002/jmri.21021. J Magn Reson Imaging. 2007. PMID: 17685423 No abstract available.
Similar articles
-
[Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].J Mal Vasc. 2000 Dec;25(5):312-320. J Mal Vasc. 2000. PMID: 11148391 Review. French.
-
Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.Clin Radiol. 2008 Jul;63(7):744-55. doi: 10.1016/j.crad.2008.01.001. Epub 2008 Mar 28. Clin Radiol. 2008. PMID: 18555032
-
Three-dimensional contrast-enhanced MR angiography.Top Magn Reson Imaging. 1996 Dec;8(6):322-44. Top Magn Reson Imaging. 1996. PMID: 9402676 Review.
-
[Time-resolved multiphasic 3D MR angiography in the diagnosis of the pulmonary vascular system in children].Rofo. 2003 Jul;175(7):929-35. doi: 10.1055/s-2003-40430. Rofo. 2003. PMID: 12847647 Clinical Trial. German.
-
Safety risks with gadolinium-based contrast agents.J Magn Reson Imaging. 2007 Sep;26(3):816; author reply 817. doi: 10.1002/jmri.21021. J Magn Reson Imaging. 2007. PMID: 17685423 No abstract available.
Cited by
-
Double Bolus Application in TWIST-MR-Angiography of the Cervical Arteries.Radiol Res Pract. 2012;2012:203538. doi: 10.1155/2012/203538. Epub 2012 Oct 18. Radiol Res Pract. 2012. PMID: 23125928 Free PMC article.
-
Background Removal and Vessel Filtering of Noncontrast Ultrasound Images of Microvasculature.IEEE Trans Biomed Eng. 2019 Mar;66(3):831-842. doi: 10.1109/TBME.2018.2858205. Epub 2018 Jul 20. IEEE Trans Biomed Eng. 2019. PMID: 30040621 Free PMC article.
-
The Impact of Injector-Based Contrast Agent Administration on Bolus Shape and Magnetic Resonance Angiography Image Quality.Magn Reson Insights. 2017 Apr 20;10:1178623X17705894. doi: 10.1177/1178623X17705894. eCollection 2017. Magn Reson Insights. 2017. PMID: 28579796 Free PMC article.
-
Synthetic approaches to heterocyclic ligands for Gd-based MRI contrast agents.Molecules. 2007 Aug 9;12(8):1771-95. doi: 10.3390/12081771. Molecules. 2007. PMID: 17960087 Free PMC article. Review.
-
Accuracy of susceptibility-weighted imaging for the detection of arteriovenous shunting in vascular malformations of the brain.Stroke. 2011 Jan;42(1):87-92. doi: 10.1161/STROKEAHA.110.584862. Epub 2010 Nov 18. Stroke. 2011. PMID: 21088245 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials